Zehren John 4
4 · ENDOLOGIX INC /DE/ · Filed Aug 6, 2019
Insider Transaction Report
Form 4
Zehren John
Chief Commercial Officer
Transactions
- Award
Common Stock
2019-08-05+15,300→ 42,864 total - Award
Option to Purchase
2019-08-05$6.67/sh+30,600$204,102→ 30,600 totalExercise: $6.67From: 2019-09-05Exp: 2029-08-05→ Common Stock (30,600 underlying)
Footnotes (2)
- [F1]Performance restricted stock unit award based on predetermined goals.
- [F2]Options vest ratably over thirty-six months.